HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-07-18 for HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM manufactured by Accriva Diagnostics.

Event Text Entries

[114676750] This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite, serial number (b)(4), the parent case. This mdr also captures a child complaint (b)(4)for the hemochron jr act-lr (low-range) reagent cuvette used. Method codes: analysis of production records. No history of service or repairs. Results code: no findings available. Conclusion code: conclusion not yet available. Accriva diagnostics has requested all data required for form 3500a. This is the initial 30-day report that precedes the instrument evaluation. Mdr follow-up #1 will be submitted if the device is returned to the manufacturer for evaluation.
Patient Sequence No: 1, Text Type: N, H10


[114676751] Healthcare professional reported that a hemochron signature elite and low-range act system reported higher than expected act results during a pci procedure. The patient was receiving intravenous heparin with a target act of >250 seconds. One blood sample generated an act result that was >400 seconds, which was a higher than expected result. Another blood sample drawn 12 minutes was assayed on a second hemochron signature elite with the same lot of reagent cuvettes, which generated an act result of 180 seconds, which was an expected result. An intravenous bolus dose of heparin was administered and the procedure was successfully completed. The hemochron signature elite and low-range act system passed electronic and liquid qc before the procedure. No bleeding or medical complications were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2250033-2018-00016
MDR Report Key7701010
Report SourceHEALTH PROFESSIONAL
Date Received2018-07-18
Date of Report2018-08-09
Date of Event2018-06-21
Date Mfgr Received2018-07-24
Device Manufacturer Date2017-07-17
Date Added to Maude2018-07-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Manufacturer G1ACCRIVA DIAGNOCTICS
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM
Generic NameSYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Product CodeJPA
Date Received2018-07-18
Returned To Mfg2018-07-24
Model NumberELITE
Catalog NumberELITE
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer Address6260 SEQUENCE DRIVE SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
10 2018-07-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.